BACKGROUND/AIMS: Excessive daytime sleepiness (EDS) is frequent in patients with Parkinson's disease (PD). Occasionally, EDS in PD exhibits narcolepsy-like features. We aimed to assess characteristics and determinants of EDS in consecutive patients with PD. METHODS: Thirty consecutive patients with PD underwent a detailed clinical examination. EDS was assessed using the Epworth Sleepiness Scale (ESS) and Multiple Sleep Latency Test (MSLT). Sleep was assessed using video-polysomnography. Cerebrospinal fluid (CSF) hypocretin-1 levels were obtained in 3 patients. RESULTS: ESS was >10 in 17 patients (57%). Mean sleep latency (MSL) on MSLT was <5 min in 11 patients (37%). There was a significant negative correlation between ESS and MSL. None of the 11 patients with MSL <5 min showed a sleep onset REM (SOREM) episode. Patients with EDS had higher dopamine agonists/levodopa equivalent doses, higher apnea/hypopnea index and exhibited wearing-off symptoms more often. Hypocretin-1 was normal in 3 patients tested. CONCLUSION: EDS, which can sometimes be severe, is common in PD patients even in the absence of SOREM and detectable CSF-hypocretin deficiency. In PD, EDS is a multifaceted phenomenon, the determinants of which include severity of PD, wearing-off symptoms, dosage of antiparkinsonian drugs and sleep-disordered breathing. Copyright 2010 S. Karger AG, Basel.
BACKGROUND/AIMS: Excessive daytime sleepiness (EDS) is frequent in patients with Parkinson's disease (PD). Occasionally, EDS in PD exhibits narcolepsy-like features. We aimed to assess characteristics and determinants of EDS in consecutive patients with PD. METHODS: Thirty consecutive patients with PD underwent a detailed clinical examination. EDS was assessed using the Epworth Sleepiness Scale (ESS) and Multiple Sleep Latency Test (MSLT). Sleep was assessed using video-polysomnography. Cerebrospinal fluid (CSF) hypocretin-1 levels were obtained in 3 patients. RESULTS:ESS was >10 in 17 patients (57%). Mean sleep latency (MSL) on MSLT was <5 min in 11 patients (37%). There was a significant negative correlation between ESS and MSL. None of the 11 patients with MSL <5 min showed a sleep onset REM (SOREM) episode. Patients with EDS had higher dopamine agonists/levodopa equivalent doses, higher apnea/hypopnea index and exhibited wearing-off symptoms more often. Hypocretin-1 was normal in 3 patients tested. CONCLUSION: EDS, which can sometimes be severe, is common in PDpatients even in the absence of SOREM and detectable CSF-hypocretin deficiency. In PD, EDS is a multifaceted phenomenon, the determinants of which include severity of PD, wearing-off symptoms, dosage of antiparkinsonian drugs and sleep-disordered breathing. Copyright 2010 S. Karger AG, Basel.
Authors: Donald L Bliwise; Lynn Marie Trotti; Jorge J Juncos; Stewart A Factor; Alan Freeman; David B Rye Journal: Parkinsonism Relat Disord Date: 2012-08-29 Impact factor: 4.891
Authors: Amy W Amara; Lama M Chahine; Chelsea Caspell-Garcia; Jeffrey D Long; Christopher Coffey; Birgit Högl; Aleksandar Videnovic; Alex Iranzo; Geert Mayer; Nancy Foldvary-Schaefer; Ron Postuma; Wolfgang Oertel; Shirley Lasch; Ken Marek; Tanya Simuni Journal: J Neurol Neurosurg Psychiatry Date: 2017-05-29 Impact factor: 10.154
Authors: Donald L Bliwise; Lynn Marie Trotti; Anthony G Wilson; Sophia A Greer; Cathy Wood-Siverio; Jorge J Juncos; Stewart A Factor; Alan Freeman; David B Rye Journal: Mov Disord Date: 2012-07-02 Impact factor: 10.338
Authors: Seockhoon Chung; Nicolaas I Bohnen; Roger L Albin; Kirk A Frey; Martijn L T M Müller; Ronald D Chervin Journal: J Clin Sleep Med Date: 2013-11-15 Impact factor: 4.062
Authors: Meredith Spindler; Nalaka S Gooneratne; Andrew Siderowf; John E Duda; Charles Cantor; Nabila Dahodwala Journal: J Parkinsons Dis Date: 2013-01-01 Impact factor: 5.568